(Q33501103)

English

Phase I study of daily times five topotecan and single injection of cisplatin in patients with previously untreated non-small-cell lung carcinoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Phase I study of daily times five topotecan and single injection of cisplatin in patients with previously untreated non-small-cell lung carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

non-small-cell lung carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

E Raymond

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

H A Burris

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

E K Rowinsky

3

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

J R Eckardt

4

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

G Rodriguez

5

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

L Smith

6

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

G Weiss

7

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

D D Von Hoff

8

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

publication date

1 October 1997

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1003-1008

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

The current status of camptothecin analogues as antitumor agents

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253314126

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA topoisomerases: essential enzymes and lethal targets

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253314126

7 January 2021

based on heuristic

inferred from DOI database lookup

Camptothecin cytotoxicity in mammalian cells is associated with the induction of persistent double strand breaks in replicating DNA.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253314126

7 January 2021

based on heuristic

inferred from DOI database lookup

Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253314126

7 January 2021

based on heuristic

inferred from DOI database lookup

Preclinical and phase I trials of topoisomerase I inhibitors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253314126

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of topotecan, a new topoisomerase I inhibitor, against human tumor colony-forming units in vitro

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253314126

7 January 2021

based on heuristic

inferred from DOI database lookup

Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253314126

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytotoxic effects of topotecan combined with various anticancer agents in human cancer cell lines

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253314126

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of topoisomerase modulators on cisplatin cytotoxicity in human ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253314126

7 January 2021

based on heuristic

inferred from DOI database lookup

Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253314126

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitor

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253314126

7 January 2021

based on heuristic

inferred from DOI database lookup

Camptothecin analogues: studies from the Johns Hopkins Oncology Center.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253314126

7 January 2021

based on heuristic

inferred from DOI database lookup

Topotecan today

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253314126

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of topotecan and cisplatin in patients with advanced solid tumors: a cancer and leukemia group B study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253314126

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I and pharmacologic study of topotecan in patients with impaired renal function

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253314126

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased poly(ADP-ribosyl)ation in intact cells by cisplatin treatment.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253314126

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment-related fatal sepsis from topotecan/cisplatin and topotecan/paclitaxel

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253314126

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequences of topotecan and cisplatin: phase I, pharmacologic, and in vitro studies to examine sequence dependence

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008253314126

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008253314126

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33501103&oldid=1615290229"